Forte BiosciencesFBRX
13F holders, Q1 2025 (March 31)29holders +3
5new positions
2sold out
1famous investor
$7.81avg. 13F price*
At the end of Q1 2025, 29 institutions reported holding Forte Biosciences Inc. (FBRX) in their 13F filings, up 3 from Q4 2024. 5 opened new positions and 2 sold out. The largest holders were Janus Henderson Group PLC ($7.4M), Fred Alger Management, LLC ($7.1M) and Tybourne Capital Management (hk) Ltd. ($4.8M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Forte Biosciences Inc.
- CUSIP
- 34962G208
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $7.6M |
| Exits | 2 | $2.2M |
All 13F filers, Q4 2024 → Q1 2025: 1,087,204 shares bought and 328,538 shares sold, net +758,666 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Janus Henderson Group PLC | 0.00% | New | 920,000 | $7.4M |
| Fred Alger Management, LLC | 0.04% | Reduce -19.7% | 910,609 | $7.1M |
| Tybourne Capital Management (hk) Ltd. | 20.42% | No change | 619,981 | $4.8M |
| Ikarian Capital, LLC | 1.54% | No change | 609,225 | $4.7M |
| BVF Inc. | 0.19% | No change | 594,282 | $4.6M |
| Orbimed Advisors LLC | 0.11% | Reduce -1.1% | 593,088 | $4.6M |
| Cable Car Capital, LP | 1.96% | No change | 219,604 | $1.7M |
| Woodline Partners LP | 0.01% | Add +0.3% | 204,822 | $1.6M |
| Boothbay Fund Management, LLC | 0.03% | No change | 89,191 | $692K |
| Vanguard Group Inc. | 0.00% | Add +237.0% | 88,951 | $690K |
| Farallon Capital Management, L.L.C. | 0.00% | Add +101.2% | 70,429 | $547K |
| Geode Capital Management, LLC | 0.00% | Add +256.0% | 60,082 | $466K |
| Acuta Capital Partners, LLC | 0.17% | Add +1.8% | 18,469 | $143K |
| Millennium Management | 0.00% | New | 14,605 | $113K |
| BlackRock, Inc. | 0.00% | No change | 6,803 | $53K |
| AlphaQuest LLC | 0.00% | New | 4,217 | $33K |
| Garde Capital, Inc. | 0.00% | New | 3,960 | $31K |
| Royal Bank of Canada | 0.00% | Reduce -11.7% | 3,342 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1692.0% | 1,792 | $14K |
| UBS Group AG | 0.00% | New | 527 | $4K |
| Comerica Bank | 0.00% | Add +176.8% | 155 | $1K |
| Morgan Stanley | 0.00% | No change | 151 | $1K |
| Group One Trading LLC | 0.00% | No change | 104 | $807 |
| Bank of America Corp. | 0.00% | Add +360.0% | 46 | $357 |
| Private Trust Co. NA | 0.00% | No change | 42 | $326 |
| SBI Securities Co., Ltd. | 0.00% | No change | 12 | $93 |
| BNP Paribas Financial Markets | 0.00% | No change | 8 | $62 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.9% | 3 | $23 |
| REAP Financial Group, LLC | 0.00% | No change | 3 | $23 |
"% of holder's portfolio" is FBRX's weight in each manager's 13F, not the share of Forte Biosciences Inc. the manager owns.